Molecular Breeding - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the molecular breeding market size was valued at USD 5.5 billion in 2025 and estimated to grow from USD 6.04 billion in 2026 to reach USD 9.62 billion by 2031, at a CAGR of 9.78% during the forecast period (2026-2031).

This report is Segmented by Application (Plant, Livestock, and More), by Marker Type (Simple Sequence Repeats (SSR), and More), by Breeding Process (Marker-Assisted Selection (MAS), and More), by Trait Target (Yield Enhancement, and More), by End-User (Seed and Crop-Protection Companies, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Molecular Breeding Market Trends and Insights

Expanding Biotechnology Research and Development Funding

Private and public spending in the market is increasing rapidly. Thermo Fisher invested USD 1.3 billion in research and development in 2023 to advance next-generation sequencing and reagent innovation, reducing entry costs for midsized breeders. The U.S. Department of Agriculture's data-standards programs are harmonizing genomic datasets, preventing redundant trials, and reducing time-to-market. These capital investments have decreased compliance barriers for smaller firms, enabling novel trait developers to navigate regulatory requirements. Additionally, multilateral initiatives, such as CGIAR's USD 400 million nutrition-focused portfolio, are attracting donor funds and accelerating biofortification outcomes.

Growing Demand for High-Yield, Climate-Resilient Crops

India's release of 100-day wheat varieties capable of withstanding record temperatures has enabled heat- and drought-tolerant genotypes to advance from pilot to commercial scale. Japanese research centers are developing quinoa and soybean varieties adapted to saline and water-stress conditions to maintain production levels in climate-vulnerable countries. Plant breeding priorities now extend beyond yield optimization to include multistress tolerance, necessitating the use of multiplexed molecular markers that integrate productivity with environmental resilience. The financial implications are significant, as extreme weather events currently cause crop losses worth billions of USD per season, increasing the return on investment for climate-resilient seed portfolios.

Stringent, Slow-Moving Regulatory Approvals

The compliance cost per new trait can reach USD 15 million, consuming approximately half of the total development budgets and deterring smaller innovators. The European Union's regulation of gene-edited crops under GMO legislation drives companies to focus on markets with favorable regulations, such as the United States and Brazil. While Argentina, Uruguay, and Thailand updated their regulations in 2024 to simplify approvals, regulatory uncertainty continues to extend timelines and increase financing costs.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid Adoption of Precision Breeding and Phenotyping Platforms
2. Government-Backed Food Security Initiatives
3. High Capital Cost of Sequencing and Genotyping Infrastructure

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Plant applications accounted for 62.35% of the molecular breeding market in 2025, primarily through genomic selection implementation in maize, wheat, and soybean breeding programs. The livestock segment is experiencing growth at a 12.64% CAGR, driven by genomic breeding values that demonstrate superior performance compared to traditional estimates in dairy cattle and CRISPR-based disease-resistant pig development. Tools such as Angus SteerSELECT have demonstrated prediction accuracies exceeding 0.72 for critical carcass traits, enhancing feedlot profitability and attracting investment.

The poultry sector is implementing precision editing of fertility and growth genes to reduce generation intervals. Furthermore, integrated metabolomic and genomic models in swine breeding demonstrate potential for improving average daily gain, despite current modest outcomes. These developments indicate that the livestock segment may substantially increase its contribution to the molecular breeding market by 2031.

Single nucleotide polymorphisms (SNPs) accounted for 41.55% of the molecular breeding market size in 2025 and maintain a 12.85% CAGR due to their compatibility with high-throughput platforms and enhanced genome-wide association outputs. The reduction in unit costs has diminished the price advantage previously held by simple sequence repeats, prompting developing-country programs to adopt SNP solutions directly. The implementation of functional-variant panels from RNA-seq and ATAC-seq data has improved breeding accuracies by 3 percentage points in dairy-protein traits, demonstrating the technology's reliability.

The standardization of SNP workflows has positioned express sequence tags and other traditional markers primarily in specialized applications such as expression profiling. The increased adoption of SNPs enhances data interoperability, which is fundamental for developing AI-enabled breeding systems.

Complete Report Scope:

• By Application
  • Plant
  • Livestock
  • Other Application
• By Marker Type
  • Simple Sequence Repeats (SSR)
  • Single Nucleotide Polymorphisms (SNP)
  • Expressed Sequence Tags (EST)
  • Other Markers
• By Breeding Process
  • Marker-Assisted Selection (MAS)
  • Quantitative Trait Loci (QTL) Mapping
  • Marker-Assisted Back-Crossing
  • Genomic Selection
• By Trait Target
  • Yield Enhancement
  • Disease and Pest Resistance
  • Abiotic Stress Tolerance
  • Quality and Nutritional Traits
• By End-User
  • Seed and Crop-Protection Companies
  • Livestock Breeding Firms
  • Academic and Government Research Institutes
  • Independent Breeding Service Providers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Russia
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Turkey
    • Rest of Middle East
  • Africa
    • South Africa
    • Nigeria
    • Rest of Africa

Geography Analysis

North America holds 35.55% of the molecular breeding market share in 2025, supported by advanced research infrastructure and efficient regulatory frameworks. Illumina reported USD 4.33 billion revenue in 2024 and has partnered with LGC Biosearch Technologies to increase targeted genotyping-by-sequencing capabilities for row-crop and livestock segments. The USDA's SECURE rule streamlines the approval process for gene-edited products, maintaining the region's market leadership.

Asia-Pacific demonstrates the highest growth potential with a projected 11.45% CAGR through 2031. China approved disease-resistant gene-edited wheat in 2024, while India's regulatory updates streamline approvals for specific genome edits, accelerating private breeding initiatives. Japan's tiered regulatory system and focus on crop-stress research establishes it as a key regional hub. The combination of government funding and private venture capital is strengthening the region's breeding infrastructure to address food security needs.

Europe maintains significant market presence despite regulatory constraints. The EU Environment Committee's approval of new genomic technology legislation in late 2024 indicates movement toward risk-based assessment. The UK implemented the Precision Breeding Act, establishing a two-tier safety review system to expedite gene-edited crop trials. Switzerland is implementing similar regulatory changes. Market growth depends on policy developments, with substantial demand for varieties meeting European Green Deal sustainability requirements.

1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. LGC Limited (Cinven)
4. Eurofins Scientific
5. SGS SA
6. Agilent Technologies, Inc.
7. DanBred P/S
8. LemnaTec GmbH (Nynomic AG)
9. Charles River Laboratories
10. Intertek Group plc
11. KeyGene NV
12. Syngenta AG
13. Corteva Agriscience
14. Bayer AG
15. BASF SE
16. Sequentia Biotech SL
17. Hudson Alpha

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support